CHE Form 144: Executive to Sell 150 Shares via J.P. Morgan on NYSE

Rhea-AI Filing Summary

Chemed Corporation (CHE) Form 144 disclosure: A notice was filed reporting a proposed sale of 150 shares of the issuer's capital stock through J.P. Morgan Securities LLC on the NYSE, with an approximate sale date of 09/09/2025 and an aggregate market value of 69,567. The shares were acquired on 05/29/2025 as executive compensation from the issuer; the filing shows 277 shares were originally acquired on that date and payment was made on 05/29/2025. The filer reports 14,571,695 shares outstanding for the class. No securities were reported sold by the person in the past three months in this filing.

Positive

• Required insider sale disclosure provided, including broker, number of shares, and planned sale date
• Acquisition source and payment details are documented: shares were received as executive compensation on 05/29/2025

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine Form 144 disclosing an executive's planned sale of 150 shares; informational rather than material.

The filing simply notifies the market that an individual who received 277 shares as executive compensation on 05/29/2025 intends to sell 150 shares via J.P. Morgan on 09/09/2025. The document contains no earnings, guidance, or operational details—only required transaction disclosure. For investors, this is a compliance-level disclosure that signals a planned insider sale but provides no new information about company performance.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure showing an insider sale tied to executive compensation; no governance concerns evident from the form alone.

The filer certifies the absence of undisclosed material adverse information and records the sale plan details as required by Rule 144. The form notes the securities were received as executive compensation and that there were no securities sold in the past three months by the person. As filed, the notice is a standard transparency measure; it does not indicate any improper conduct or governance action beyond routine insider selling disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Capital Stock	J.P. Morgan Securities LLC 390 Madison Avenue, 6th Floor New York NY 10017	150	69567	14571695	09/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Capital Stock	05/29/2025	Executive Compensation	Issuer			277	05/29/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Chemed Corporation (CHE) Form 144 disclose?

The filing discloses a proposed sale of 150 shares of Chemed capital stock through J.P. Morgan Securities LLC on 09/09/2025 with an aggregate market value of 69,567.

When and how were the shares being sold acquired according to the filing?

The filing states 277 shares were acquired on 05/29/2025 as executive compensation, with payment noted on 05/29/2025.

How many shares outstanding does the filing report for the class?

The form lists 14,571,695 shares outstanding for the class of capital stock.

Were any shares sold by the filer in the past three months?

The filing indicates Nothing to Report under securities sold during the past three months.

Which broker and exchange are named in the proposed sale?

The broker is J.P. Morgan Securities LLC and the securities are to be sold on the NYSE.